Briefing

The Briefing: Slice Lands $40M For Pizzeria Tech, Connected Cannabis Rolls Up $30M, And More

The Briefing

Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know.

Subscribe to the Crunchbase Daily

Funding rounds

Slice picks up $40m for pizzeria platform: New York-based Slice, a provider of tools for pizzerias to manage the digital side of their businesses, announced that it raised $40 million in a Series D funding round led by Cross Creek.  The company says it has over 15,000 local pizzerias in its network and focuses on helping shops build their digital market share and eliminate dependence on third-party delivery apps.

Connected Cannabis rolls up $30M: Connected Cannabis, a cultivator of designer cannabis strains, reported that it raised $30 million in debt and equity financing led by existing investors. The company plans to use the funds to fuel its national expansion as more U.S. states legalize marijuana.

— Joanna Glasner

Health care

Benchling raises $200M: Benchling, a San Francisco-based life sciences R&D cloud company, raised $200 million in Series E funding, led by Sequoia Capital Global Equities. The cloud-based software platform has been used by more than 230,000 scientists and 1,000 R&D organizations to centralize large and complex experimental datasets, as well as optimize R&D processes so they can make breakthrough discoveries faster, according to the company. The new funding lifts Benchling’s total funding to $211.9 million since its launch in 2012, according to Crunchbase data. The company previously raised a $50 million Series D round last May. Benchling said the new funding will be invested in product development and global expansion to support enterprise customers.

ImmunoScape lands $14M: Singapore-based biotech company ImmunoScape secured a $14 million round of funding co-led by existing investors Anzu Partners and UTEC – The University of Tokyo Edge Capital Partners, as well as new investor EDBI. The new round brings ImmunoScape’s total funding in the past year to $25 million, according to the company. ImmunoScape’s platform integrates single-cell analysis technologies and bioinformatics for both drug discovery and high-dimensional immune profiling.

— Christine Hall

Public market

Nasdaq sets Coinbase reference price ahead of market debut: Nasdaq gave Coinbase a reference price of $250 a share ahead of Wednesday’s planned direct listing. At that share price, the cryptocurrency exchange would be valued at about $65.3 billion on a fully diluted basis, CNBC reports.

As the first major U.S. crypto-related public offering, there’s been pent-up anticipation around the debut, with much speculation that the company could exceed the $100 billion valuation threshold. Go here to see how the market reacted.

— Joanna Glasner

Illustration: Dom Guzman

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

Copy link